| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | scaffold protein binding | 1.12e-05 | 93 | 63 | 5 | GO:0097110 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 2.75e-05 | 3 | 63 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 5.49e-05 | 4 | 63 | 2 | GO:0008049 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 5.69e-05 | 4 | 65 | 2 | GO:0098983 | |
| MousePheno | abnormal mineral level | MYO7A KIF1B CYP27B1 MTMR3 SCUBE3 BAZ1B GRIA1 UBE3C NOS3 MYSM1 HYAL2 EPB42 | 4.69e-05 | 1066 | 42 | 12 | MP:0000192 |
| MousePheno | abnormal mineral homeostasis | MYO7A KIF1B CYP27B1 MTMR3 SCUBE3 BAZ1B GRIA1 UBE3C NOS3 MYSM1 HYAL2 EPB42 | 5.14e-05 | 1076 | 42 | 12 | MP:0005636 |
| MousePheno | anovulation | 1.29e-04 | 33 | 42 | 3 | MP:0008869 | |
| MousePheno | absent alveolar lamellar bodies | 1.31e-04 | 6 | 42 | 2 | MP:0010814 | |
| MousePheno | increased mineral level | 1.33e-04 | 668 | 42 | 9 | MP:0014535 | |
| MousePheno | abnormal blood urea nitrogen level | 1.42e-04 | 389 | 42 | 7 | MP:0005265 | |
| MousePheno | increased circulating alkaline phosphatase level | 1.45e-04 | 526 | 42 | 8 | MP:0002968 | |
| MousePheno | abnormal ion homeostasis | MYO7A KIF1B CYP27B1 MTMR3 SCUBE3 BAZ1B GRIA1 UBE3C NOS3 MYSM1 HYAL2 EPB42 | 1.89e-04 | 1232 | 42 | 12 | MP:0001765 |
| Domain | NLGN4 | 1.12e-05 | 2 | 63 | 2 | IPR030025 | |
| Domain | Nucleoside_tran | 6.69e-05 | 4 | 63 | 2 | PF01733 | |
| Domain | Eqnu_transpt | 6.69e-05 | 4 | 63 | 2 | IPR002259 | |
| Domain | Nlgn | 1.11e-04 | 5 | 63 | 2 | IPR000460 | |
| Domain | TSP_3 | 1.11e-04 | 5 | 63 | 2 | PF02412 | |
| Domain | TSP3 | 1.11e-04 | 5 | 63 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.11e-04 | 5 | 63 | 2 | PS51236 | |
| Domain | - | 1.11e-04 | 5 | 63 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.11e-04 | 5 | 63 | 2 | IPR008859 | |
| Domain | TSP_C | 1.11e-04 | 5 | 63 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.11e-04 | 5 | 63 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 1.11e-04 | 5 | 63 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.11e-04 | 5 | 63 | 2 | IPR028974 | |
| Domain | VWC | 2.84e-04 | 38 | 63 | 3 | SM00214 | |
| Domain | HATC_C_dom | 3.09e-04 | 8 | 63 | 2 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 3.09e-04 | 8 | 63 | 2 | PF05699 | |
| Domain | VWF_dom | 3.82e-04 | 42 | 63 | 3 | IPR001007 | |
| Domain | PH_dom-spectrin-type | 3.97e-04 | 9 | 63 | 2 | IPR001605 | |
| Domain | EGF_3 | 7.23e-04 | 12 | 63 | 2 | PF12947 | |
| Domain | EGF_dom | 7.23e-04 | 12 | 63 | 2 | IPR024731 | |
| Domain | Carboxylesterase_B_CS | 8.53e-04 | 13 | 63 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 9.93e-04 | 14 | 63 | 2 | PS00941 | |
| Domain | COesterase | 9.93e-04 | 14 | 63 | 2 | PF00135 | |
| Domain | CarbesteraseB | 9.93e-04 | 14 | 63 | 2 | IPR002018 | |
| Domain | - | 1.14e-03 | 15 | 63 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 1.14e-03 | 15 | 63 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 1.14e-03 | 15 | 63 | 2 | IPR023394 | |
| Domain | EGF | 1.17e-03 | 235 | 63 | 5 | SM00181 | |
| Domain | Sec7 | 1.30e-03 | 16 | 63 | 2 | SM00222 | |
| Domain | SEC7 | 1.30e-03 | 16 | 63 | 2 | PS50190 | |
| Domain | Sec7_dom | 1.30e-03 | 16 | 63 | 2 | IPR000904 | |
| Domain | EGF-like_dom | 1.52e-03 | 249 | 63 | 5 | IPR000742 | |
| Domain | IQ | 1.78e-03 | 71 | 63 | 3 | PF00612 | |
| Domain | - | 2.01e-03 | 391 | 63 | 6 | 2.30.29.30 | |
| Domain | IQ | 2.59e-03 | 81 | 63 | 3 | SM00015 | |
| Domain | TSPN | 2.71e-03 | 23 | 63 | 2 | SM00210 | |
| Domain | EGF_CA | 3.07e-03 | 86 | 63 | 3 | PF07645 | |
| Domain | PH_dom-like | 3.08e-03 | 426 | 63 | 6 | IPR011993 | |
| Domain | IQ_motif_EF-hand-BS | 3.49e-03 | 90 | 63 | 3 | IPR000048 | |
| Domain | IQ | 3.82e-03 | 93 | 63 | 3 | PS50096 | |
| Domain | VWC | 4.00e-03 | 28 | 63 | 2 | PF00093 | |
| Domain | VWFC_1 | 6.55e-03 | 36 | 63 | 2 | PS01208 | |
| Domain | Myosin_head_motor_dom | 7.28e-03 | 38 | 63 | 2 | IPR001609 | |
| Domain | VWFC_2 | 7.28e-03 | 38 | 63 | 2 | PS50184 | |
| Domain | MYOSIN_MOTOR | 7.28e-03 | 38 | 63 | 2 | PS51456 | |
| Domain | Myosin_head | 7.28e-03 | 38 | 63 | 2 | PF00063 | |
| Domain | MYSc | 7.28e-03 | 38 | 63 | 2 | SM00242 | |
| Domain | EGF_CA | 8.12e-03 | 122 | 63 | 3 | SM00179 | |
| Domain | EGF_3 | 8.15e-03 | 235 | 63 | 4 | PS50026 | |
| Pubmed | 7.41e-07 | 10 | 65 | 3 | 16707115 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 3.44e-06 | 2 | 65 | 2 | 16181801 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17620335 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 3.44e-06 | 2 | 65 | 2 | 23660684 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 39122122 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 34425286 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 3.44e-06 | 2 | 65 | 2 | 22930728 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 3.44e-06 | 2 | 65 | 2 | 8126073 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 38339060 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 18434543 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 33372257 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21762961 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 9694593 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 23183221 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 24855039 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 12213711 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 3.44e-06 | 2 | 65 | 2 | 37001827 | |
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 3.44e-06 | 2 | 65 | 2 | 12358136 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 3.44e-06 | 2 | 65 | 2 | 37080762 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 3.44e-06 | 2 | 65 | 2 | 1712771 | |
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 3.44e-06 | 2 | 65 | 2 | 10027393 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 29106499 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 3.44e-06 | 2 | 65 | 2 | 24104404 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 3.44e-06 | 2 | 65 | 2 | 32243781 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 33981184 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21949402 | ||
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 3.44e-06 | 2 | 65 | 2 | 18594557 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 22989184 | ||
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 3.44e-06 | 2 | 65 | 2 | 15037577 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30928339 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 17143334 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 3.44e-06 | 2 | 65 | 2 | 33759165 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 26241338 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 9373030 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 1.03e-05 | 3 | 65 | 2 | 18787106 | |
| Pubmed | USP9x-mediated deubiquitination of EFA6 regulates de novo tight junction assembly. | 1.03e-05 | 3 | 65 | 2 | 20339350 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 18032585 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 19109486 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 19818485 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21059996 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 32011705 | ||
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 1.03e-05 | 3 | 65 | 2 | 17638877 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30939949 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 1.03e-05 | 3 | 65 | 2 | 17442977 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 19004835 | ||
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 1.03e-05 | 3 | 65 | 2 | 8463250 | |
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 1.03e-05 | 3 | 65 | 2 | 12482844 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 16311602 | ||
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 1.03e-05 | 3 | 65 | 2 | 26168731 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 1.03e-05 | 3 | 65 | 2 | 16598380 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 18628683 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 27513329 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 15347840 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 25976449 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 31092423 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 1.03e-05 | 3 | 65 | 2 | 1459996 | |
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 1.03e-05 | 3 | 65 | 2 | 21282647 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 18178577 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 1.03e-05 | 3 | 65 | 2 | 8400410 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 33069367 | ||
| Pubmed | Nucleoside transporters are widely expressed in ovarian carcinoma effusions. | 2.06e-05 | 4 | 65 | 2 | 21822668 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 19147503 | ||
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 2.06e-05 | 4 | 65 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 2.06e-05 | 4 | 65 | 2 | 22671294 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20579107 | ||
| Pubmed | The mouse and human genes encoding the recognition component of the N-end rule pathway. | 2.06e-05 | 4 | 65 | 2 | 9653112 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 16077734 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 12446811 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 2.06e-05 | 4 | 65 | 2 | 6338048 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 17292328 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 18089612 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 12909644 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 11980922 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 10900205 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20847111 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 30622267 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 17615572 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 3.43e-05 | 5 | 65 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 3.43e-05 | 5 | 65 | 2 | 10996085 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 23806329 | ||
| Pubmed | EFA6 activates Arf6 and participates in its targeting to the Flemming body during cytokinesis. | 3.43e-05 | 5 | 65 | 2 | 23603394 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 37865312 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 21838267 | ||
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 29724786 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 25149275 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 8.36e-05 | 759 | 65 | 8 | 35915203 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 9.56e-05 | 8 | 65 | 2 | 30871858 | |
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 9.56e-05 | 8 | 65 | 2 | 24460873 | |
| Pubmed | 1.14e-04 | 407 | 65 | 6 | 12693553 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 1371115 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 23010509 | ||
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 1.23e-04 | 9 | 65 | 2 | 29252214 | |
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 1.29e-04 | 52 | 65 | 3 | 30389913 | |
| Pubmed | USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses. | 1.53e-04 | 10 | 65 | 2 | 25538220 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 32973045 | ||
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 26403076 | ||
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 2.65e-04 | 13 | 65 | 2 | 27050589 | |
| Pubmed | Contribution of adenosine related genes to the risk of depression with disturbed sleep. | 2.65e-04 | 13 | 65 | 2 | 20392501 | |
| Cytoband | 7p22.1 | 4.20e-05 | 47 | 65 | 3 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 9.30e-04 | 134 | 65 | 3 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 1.52e-03 | 159 | 65 | 3 | chr7q36 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-06 | 175 | 65 | 5 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 176 | 65 | 5 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 176 | 65 | 5 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 178 | 65 | 5 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-06 | 178 | 65 | 5 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.57e-06 | 190 | 65 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 197 | 65 | 5 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 97 | 65 | 4 | a1279377bf0ee5662db8b9303f5f1fd418dee6df | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 97 | 65 | 4 | 12cbd03b33e76e5e471bbee2a9c11f27e8b21123 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-05 | 162 | 65 | 4 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 166 | 65 | 4 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 166 | 65 | 4 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 171 | 65 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 172 | 65 | 4 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.19e-04 | 173 | 65 | 4 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 173 | 65 | 4 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-04 | 173 | 65 | 4 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 175 | 65 | 4 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 176 | 65 | 4 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-04 | 176 | 65 | 4 | 6b04672f295d7680ba00714a72785314a619c893 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-04 | 177 | 65 | 4 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-04 | 177 | 65 | 4 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 178 | 65 | 4 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 179 | 65 | 4 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 181 | 65 | 4 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 181 | 65 | 4 | 2392af8c7f040c23a7d416c2e37419954970c8f4 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 184 | 65 | 4 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 1.51e-04 | 184 | 65 | 4 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-04 | 184 | 65 | 4 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 1.54e-04 | 185 | 65 | 4 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.57e-04 | 186 | 65 | 4 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.60e-04 | 187 | 65 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 187 | 65 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 187 | 65 | 4 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 1.60e-04 | 187 | 65 | 4 | 9000241566f48e435db9409b7255db68b68f6059 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 187 | 65 | 4 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-04 | 187 | 65 | 4 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_memory|ICU-SEP / Disease, Lineage and Cell Type | 1.64e-04 | 188 | 65 | 4 | b6d81be72bbd72a68722ab51d1a72c436ef9bc17 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 188 | 65 | 4 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.64e-04 | 188 | 65 | 4 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 188 | 65 | 4 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 188 | 65 | 4 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | MS-CD4-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.67e-04 | 73 | 65 | 3 | b23c66d8028cd122df76311a47b0f2cefc2efcc6 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-04 | 189 | 65 | 4 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 190 | 65 | 4 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster | 1.74e-04 | 191 | 65 | 4 | 4dd9c8117c4499ed9bde127baf2598603a82080d | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 191 | 65 | 4 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 191 | 65 | 4 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 192 | 65 | 4 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.81e-04 | 193 | 65 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.85e-04 | 194 | 65 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.85e-04 | 194 | 65 | 4 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 194 | 65 | 4 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 194 | 65 | 4 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.85e-04 | 194 | 65 | 4 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 195 | 65 | 4 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.88e-04 | 195 | 65 | 4 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.88e-04 | 195 | 65 | 4 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.88e-04 | 195 | 65 | 4 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 195 | 65 | 4 | eaadc79f53b1cb208c6f7999925f318e1378197f | |
| ToppCell | facs-Skin-nan-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 196 | 65 | 4 | 81f9754567bbfa67edd304b9ef7b03e7bd9a3b52 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-|Liver / Manually curated celltypes from each tissue | 1.92e-04 | 196 | 65 | 4 | 4ad73515af265432235b698fceb0ba370ced3e52 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-04 | 196 | 65 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | moderate-Lymphoid-NKT|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-04 | 197 | 65 | 4 | 003950f6ed32df64014845f9ec56179512a6cecc | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-04 | 198 | 65 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-B-B_memory|ICU-SEP / Disease, condition lineage and cell class | 2.00e-04 | 198 | 65 | 4 | 4ba2eb32889bbf043f4bbb822e08eb45a2b576ef | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.00e-04 | 198 | 65 | 4 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.00e-04 | 198 | 65 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.00e-04 | 198 | 65 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.04e-04 | 199 | 65 | 4 | 6df0e8ec701c763b1cae5cabcc9e3c25cdbfe4bf | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 2.04e-04 | 199 | 65 | 4 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 199 | 65 | 4 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 199 | 65 | 4 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg|Bac-SEP / Disease, condition lineage and cell class | 2.04e-04 | 199 | 65 | 4 | e0b6136e28b813299b7ffbe37f1cf830e60cd7d8 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | COVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.08e-04 | 200 | 65 | 4 | 73e01b7bc43320a991c67a4fd0c04708f893c7ea | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | facs-Skin-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-04 | 91 | 65 | 3 | 48a2c7c4ce9d23762b314e7d2537b3bb38ce6c8e | |
| ToppCell | LA-12._Cytoplasmic_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.09e-04 | 99 | 65 | 3 | aed68765f60e54b7e2406c5f09fa744fcd844354 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.86e-04 | 105 | 65 | 3 | cfd271e2cd004d6815bcc3ce7cad86fe62b5299b | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 6.66e-04 | 117 | 65 | 3 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.16e-04 | 120 | 65 | 3 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | control-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-04 | 125 | 65 | 3 | 30f593fadbe850cedd622711005f9069ad57cc03 | |
| ToppCell | LA-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.64e-04 | 128 | 65 | 3 | 071becbe97598c2b65580b0989eb664d6fd6c85a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.07e-03 | 138 | 65 | 3 | e1e936ff4080bda2810c5fd1154a706359f377a5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.10e-03 | 139 | 65 | 3 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| Drug | BDCRB | 3.60e-06 | 11 | 65 | 3 | CID000465094 | |
| Disease | Diabetic Angiopathies | 4.39e-06 | 16 | 60 | 3 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 4.39e-06 | 16 | 60 | 3 | C0025945 | |
| Disease | uridine measurement | 1.94e-03 | 32 | 60 | 2 | EFO_0010546 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESHAWRQRLPRKYLS | 876 | Q68DN1 | |
| IHRERSYRFRSVWPE | 631 | P16452 | |
| YKTRNRALHPLWESV | 41 | Q9Y2D0 | |
| VIFKLPSNRSWHRGY | 956 | Q86UK0 | |
| ILHKIVKYRFSWPFR | 1351 | Q9UIG0 | |
| RYLAIVWPVVSRKFR | 131 | P49685 | |
| HRESRVVTWSRPYFL | 321 | Q8WYQ5 | |
| VTDKREWRPVHYAAF | 126 | Q8N9B4 | |
| HFPRTVRWFHRLRSI | 281 | Q9NXS2 | |
| VLVYSWHRDREAFPK | 46 | Q5VTT2 | |
| KYASRVFHRVRWAPE | 6 | O15528 | |
| HTWFLKRIRSSQYPL | 266 | P0C881 | |
| HTWFLKRIRSSQYPL | 266 | B2RC85 | |
| WIHARSTRKKRCPYT | 186 | P31274 | |
| YRFSIRKQRPWHPAV | 51 | Q96G91 | |
| LRYVKAVRPRHLWGF | 191 | Q12891 | |
| SNWAKHFVVVRRPYV | 1716 | O60333 | |
| PRVFAWVYRHQARHK | 156 | Q6ZT52 | |
| KTWHFTIRQYRELVP | 156 | O43679 | |
| NAVPSHVFRRAWRKL | 371 | O75564 | |
| ARRPISISRDWHGYK | 176 | Q8IXQ8 | |
| WYVTVFPLRALHRRT | 141 | Q969F8 | |
| LAWPVADTFYRIHRR | 171 | Q9HCC8 | |
| RVYFRNRWVKTVHPV | 726 | P42694 | |
| RDIFSPKRSWKRQRY | 721 | P29474 | |
| VQPFRLTRWRTRYKT | 136 | Q969V1 | |
| RHTISVRVKAAPYWL | 326 | O94856 | |
| PRVRDHYRATKVAFW | 576 | Q8NFZ3 | |
| WQLTLHSRPNYTRKR | 21 | Q8NA61 | |
| IYNHSLTLSARWPRK | 2136 | Q9Y6R7 | |
| HAGEWARKPLRFYVR | 266 | P29372 | |
| KFWGRLERYLPTHSI | 381 | Q8NFI3 | |
| RDHTRVDWKRPKYTS | 276 | P42261 | |
| TYFHRKHWVRIRPLR | 106 | Q8WTZ4 | |
| LLRTPNWRPRFKFYH | 601 | Q9Y666 | |
| YERPIAFTARSRKLW | 881 | Q8IX30 | |
| RHPRKIDLRARYWAF | 91 | Q9BY12 | |
| PRVRDHYRATKVAFW | 576 | Q8N0W4 | |
| KATYERLFRWLVHRI | 426 | P35580 | |
| SFRSWKRIPAVIYRH | 211 | Q13615 | |
| NKRSWLYRILPSVSH | 56 | Q93099 | |
| LWGYRKDRTLFHPVS | 541 | Q49A17 | |
| SKRPHVFYLRTADWR | 831 | A5PKW4 | |
| RYLAVVHPTRSARWR | 141 | P32745 | |
| WSPVEKTYHSCRRRR | 931 | A0AVI2 | |
| KPHVFQLRTADWRLY | 856 | Q8NDX1 | |
| YKTPFRRNTTWHRVP | 1056 | Q9P2F8 | |
| RFHKLEKWRRPFYRV | 221 | O15466 | |
| HPPSSRWKRFYRAFL | 146 | O00623 | |
| RIFAPNHVVAKSRFW | 31 | Q02543 | |
| KPRRYLTVVFEHDAW | 381 | Q99808 | |
| YPRFLRAHWKFLKTV | 551 | O14980 | |
| TAYRWRLSHRPKTGF | 1106 | P07996 | |
| AYRHLEWPRKTQVSL | 401 | Q6ZTK2 | |
| LFSFTVKWLRRSRHI | 146 | Q96ET8 | |
| YHFRAPSRIFWRTVR | 71 | P40429 | |
| RSSYVPREILWGHRF | 296 | Q9NPI9 | |
| ILRTYSVPRLCWHFF | 106 | Q969W1 | |
| IKRTYRPRSIQRSWF | 456 | O60290 | |
| KVFRYRSGLARHWSI | 656 | Q6ZN19 | |
| WPTFRALLLHRYVVA | 336 | Q7RTT9 | |
| FVRKLYLWPRFHVAV | 186 | Q92889 | |
| RWHLTHRPKTGYIRV | 1111 | P35442 | |
| QLYVPASRHVWRFRR | 641 | Q15386 | |
| RRSAVWKHFYLSPLD | 286 | O75132 | |
| AYLVRKAFRHRLWAV | 826 | Q13402 | |
| RWIIEKYRLSHSSVP | 746 | Q5VVJ2 |